NCT04778280

Brief Summary

investigators will take stool and blood samples from two groups of humans :- 1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or case group)then investigators make estimation for vitamin D in both groups then investigators try to find if there is relation between vitamin D level and Giardia lamblia infections

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
192

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2021

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 17, 2021

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

February 25, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 3, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

March 3, 2021

Status Verified

February 1, 2021

Enrollment Period

12 months

First QC Date

February 25, 2021

Last Update Submit

February 27, 2021

Conditions

Giardia Lamblia Infection

Keywords

estimaion of vitamin D in humans infected with Giardia lamblia

Outcome Measures

Primary Outcomes (1)

  • fluctuation level of vitamin D level

    Estimation of vitamin D level in humans infected with Giardia lamblia

    1 year

Study Arms (2)

Group A

1-Group A(Healty group with negative Giardia lamblia or control group) 96 samples

Group B

2- Group B(Cases group with positive Giardia lamblia )96 sample

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

we take 192 samples then we will divide these samples into two groups :- 1. Group A (healty group with negative Giardia lamblia or control group) 2. Group B ( diseased group with positive Giardia lamblia or cases group)

You may qualify if:

  • patient infected with Giardia lamblia.

You may not qualify if:

  • patient takes vitamin D supplement - patient has kidney disease- patient has liver disease-patient has a debilitating disease disease such as cancer or diabetes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of Medicine Sohag University

Sohag, Egypt

RECRUITING

Faculty of Medicine

Sohag, Egypt

RECRUITING

MeSH Terms

Conditions

Giardiasis

Condition Hierarchy (Ancestors)

Intestinal Diseases, ParasiticParasitic DiseasesInfectionsProtozoan InfectionsIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Mohammed Sayed Farrag, Demonstrator

    faculty of medicine sohag university

    PRINCIPAL INVESTIGATOR

  • Mohammed Sayed Farrag, Demonstrator

    faculty of medicine sohag university

    STUDY DIRECTOR

Central Study Contacts

Mohammed Sayed Farrag, Demonstrator

CONTACT

01110054887mohameds_post@med.sohag.edu.eg

Noha Sammer Ahmed, Assist prof

CONTACT

01273126001

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principlal investigator

Study Record Dates

First Submitted

February 25, 2021

First Posted

March 3, 2021

Study Start

February 17, 2021

Primary Completion

February 1, 2022

Study Completion

February 1, 2022

Last Updated

March 3, 2021

Record last verified: 2021-02

Locations

EG(2)